{"id":2694,"date":"2022-10-01T11:15:59","date_gmt":"2022-10-01T11:15:59","guid":{"rendered":"https:\/\/neuropediatoolbox.org\/?p=2694"},"modified":"2022-10-15T09:49:57","modified_gmt":"2022-10-15T09:49:57","slug":"criterios-de-realizacion-de-acgh","status":"publish","type":"post","link":"https:\/\/neuropediatoolkit.org\/en\/criterios-de-realizacion-de-acgh\/","title":{"rendered":"Criteria of realization of aCGH."},"content":{"rendered":"\n<p>El <a href=\"https:\/\/es.wikipedia.org\/wiki\/Hibridaci%C3%B3n_gen%C3%B3mica_comparativa\">array de hibridaci\u00f3n gen\u00f3mica comparada (aCGH)<\/a> es la exploraci\u00f3n complementaria gen\u00e9tica de<strong> primera elecci\u00f3n<\/strong> en ni\u00f1os con <strong>retraso global del desarrollo\/discapacidad intelectual y\/o malformaciones cong\u00e9nitas m\u00faltiples<\/strong>, seg\u00fan las guias cl\u00ednicas de la AAP, la AAN, la ISCA y la ACMG. <\/p>\n\n\n\n<div id=\"wp-block-themeisle-blocks-accordion-4bd329be\" class=\"wp-block-themeisle-blocks-accordion\">\n<details class=\"wp-block-themeisle-blocks-accordion-item\"><summary class=\"wp-block-themeisle-blocks-accordion-item__title\"><div>Umbral diagn\u00f3stico:<\/div><\/summary><div class=\"wp-block-themeisle-blocks-accordion-item__content\">\n<p>Tiene la mejor rentabilidad diagn\u00f3stica considerando cada test individualmente (del 8 al 20%) superado s\u00f3lo por la evaluaci\u00f3n cl\u00ednica por parte de un cl\u00ednico especializado en retraso global del desarrollo\/discapacidad intelectual. <\/p>\n<\/div><\/details>\n<\/div>\n\n\n\n<div id=\"wp-block-themeisle-blocks-accordion-1e1d7720\" class=\"wp-block-themeisle-blocks-accordion\">\n<details class=\"wp-block-themeisle-blocks-accordion-item\"><summary class=\"wp-block-themeisle-blocks-accordion-item__title\"><div>Estratificaci\u00f3n en neuropediatr\u00eda: <\/div><\/summary><div class=\"wp-block-themeisle-blocks-accordion-item__content\">\n<p>La variaci\u00f3n en la rentabilidad diagn\u00f3stica en los distintos estudios se explica por la ausencia de estratificaci\u00f3n en funci\u00f3n de la severidad y los hallazgos asociados (otros trastornos com\u00f3rbidos, asociaci\u00f3n con malformaciones cong\u00e9nitas). <\/p>\n\n\n\n<p>Sigue siendo <strong>incierto<\/strong> si es util en los casos de <strong>discapacidad intelectual leve familiar<\/strong>. Probablemente la rentabilidad es<strong> a\u00fan menor en TEA grado 1 no sindr\u00f3mico<\/strong>. <\/p>\n\n\n\n<p>Por contra, cuando existen m\u00faltiples anomal\u00edas cong\u00e9nitas asociadas, la ACMG sigue recomend\u00e1ndolo como primera elecci\u00f3n a no ser que se sospeche un diagn\u00f3stico espec\u00edfico.<\/p>\n\n\n\n<p>Por lo tanto, tiene utilidad cl\u00ednica dividir los casos en <strong>simplex (no sindr\u00f3micos, aislados) vs complex (sindr\u00f3micos, afectaci\u00f3n m\u00e1s grave, comorbilidad)<\/strong>. <\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><thead><tr><th>Phenotype category and subcategory<\/th><th>CGH array Solved<br><em>N<\/em>&nbsp;(%)<\/th><th>Clinical exome Solved<br><em>N<\/em>&nbsp;(%)<\/th><\/tr><\/thead><tbody><tr><td>GDD\/ID (all)<\/td><td>64 (8.4%)<\/td><td>44 (26.2%)<sup>a<\/sup><\/td><\/tr><tr><td>GDD\/ID isol<\/td><td>38 (6.9%)<\/td><td>11 (16.2%)<sup>a<\/sup><\/td><\/tr><tr><td>GDD\/ID\u2009+\u2009epi<\/td><td>6 (16.7%)<\/td><td>4 (26.7%)<\/td><\/tr><tr><td>GDD\/ID\u2009+\u2009micro\/macro<\/td><td>3 (8.3%)<\/td><td>5 (55.6%)<sup>a<\/sup><\/td><\/tr><tr><td>GDD\/ID synd<\/td><td>17 (12.1%)<\/td><td>24 (31.5%)<sup>a<\/sup><\/td><\/tr><tr><td>ASD (all)<\/td><td>13 (3.0%)<\/td><td>3 (6.1%)<\/td><\/tr><tr><td>ASD isol<\/td><td>11 (2.8%)<\/td><td>0 (\u2013)<\/td><\/tr><tr><td>ASD\u2009+\u2009epi<\/td><td>0 (\u2013)<\/td><td>1 (25.0%)<\/td><\/tr><tr><td>ASD\u2009+\u2009micro\/macro<\/td><td>0 (\u2013)<\/td><td>1 (25.0%)<\/td><\/tr><tr><td>ASD synd<\/td><td>2 (7.4%)<\/td><td>1 (11.1%)<\/td><\/tr><tr><td>Other NDDs (all)<\/td><td>3 (1.4%)<\/td><td>2 (7.1%)<\/td><\/tr><tr><td>Other isol<\/td><td>3 (1.8%)<\/td><td>2 (13.3%)<\/td><\/tr><tr><td>Other\u2009+\u2009epi<\/td><td>0 (\u2013)<\/td><td>0 (\u2013)<\/td><\/tr><tr><td>Other\u2009+\u2009micro\/macro<\/td><td>0 (\u2013)<\/td><td>0 (\u2013)<\/td><\/tr><tr><td>Other synd<\/td><td>0 (\u2013)<\/td><td>0 (\u2013)<\/td><\/tr><tr><td>Total<\/td><td>80 (5.7%)<\/td><td>49 (20%)<sup>a<\/sup><\/td><\/tr><\/tbody><\/table><figcaption>https:\/\/www.nature.com\/articles\/s41525-021-00188-7<\/figcaption><\/figure>\n<\/div><\/details>\n<\/div>\n\n\n\n<p>1.&nbsp;Moeschler JB, Shevell M; Committee on Genetics&nbsp;Comprehensive evaluation of the child with intellectual disability or global developmental delays.&nbsp;<em>Pediatrics<\/em>&nbsp;2014;134(3):e903\u201318. [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25157020\">PubMed<\/a>]&nbsp;[<a rel=\"noreferrer noopener\" href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Pediatrics&amp;title=Comprehensive+evaluation+of+the+child+with+intellectual+disability+or+global+developmental+delays&amp;author=JB+Moeschler&amp;author=M+Shevell&amp;volume=134&amp;issue=3&amp;publication_year=2014&amp;pages=e903-18&amp;pmid=25157020&amp;\" target=\"_blank\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>2.&nbsp;American Academy of Neurology. Evaluation of the Child with Global Developmental Delay 2011.&nbsp;<a rel=\"noreferrer noopener\" href=\"http:\/\/www.aan.com\/guidelines\" target=\"_blank\">www.aan.com\/guidelines<\/a>&nbsp;(Accessed March 17, 2017).<\/p>\n\n\n\n<p>3.&nbsp;Silove N, Collins F, Ellaway C.&nbsp;Update on the investigation of children with delayed development.&nbsp;<em>J Paediatr Child Health<\/em>&nbsp;2013;49(7):519\u201325. [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23600797\">PubMed<\/a>]&nbsp;[<a rel=\"noreferrer noopener\" href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J+Paediatr+Child+Health&amp;title=Update+on+the+investigation+of+children+with+delayed+development&amp;author=N+Silove&amp;author=F+Collins&amp;author=C+Ellaway&amp;volume=49&amp;issue=7&amp;publication_year=2013&amp;pages=519-25&amp;pmid=23600797&amp;\" target=\"_blank\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>4.&nbsp;Manning M, Hudgins L; Professional Practice and Guidelines Committee, American College of Medical Genetics Array-based Technology and Recommendations for Utilization in Medical Genetics Practice for Detection of Chromosomal Abnormalities 2010.&nbsp;<a rel=\"noreferrer noopener\" href=\"http:\/\/www.acmg.net\/StaticContent\/PPG\/Array_based_technology_and_recommendations_for.13.pdf\" target=\"_blank\">www.acmg.net\/StaticContent\/PPG\/Array_based_technology_and_recommendations_for.13.pdf<\/a>&nbsp;(Accessed March 17, 2017).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>El array de hibridaci\u00f3n gen\u00f3mica comparada (aCGH) es la exploraci\u00f3n complementaria gen\u00e9tica de primera elecci\u00f3n en ni\u00f1os con retraso global del desarrollo\/discapacidad intelectual y\/o malformaciones cong\u00e9nitas m\u00faltiples, seg\u00fan las guias cl\u00ednicas de la AAP, la AAN, la ISCA y la ACMG. 1.&nbsp;Moeschler JB, Shevell M; Committee on Genetics&nbsp;Comprehensive evaluation of the child with intellectual disability &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/neuropediatoolkit.org\/en\/criterios-de-realizacion-de-acgh\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> \u00abCriterios de realizaci\u00f3n de aCGH.\u00bb<\/span><\/a><\/p>","protected":false},"author":1,"featured_media":2695,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[10],"tags":[],"class_list":["post-2694","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-neurogenetica","entry"],"_links":{"self":[{"href":"https:\/\/neuropediatoolkit.org\/en\/wp-json\/wp\/v2\/posts\/2694","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neuropediatoolkit.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neuropediatoolkit.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neuropediatoolkit.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/neuropediatoolkit.org\/en\/wp-json\/wp\/v2\/comments?post=2694"}],"version-history":[{"count":0,"href":"https:\/\/neuropediatoolkit.org\/en\/wp-json\/wp\/v2\/posts\/2694\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neuropediatoolkit.org\/en\/wp-json\/wp\/v2\/media\/2695"}],"wp:attachment":[{"href":"https:\/\/neuropediatoolkit.org\/en\/wp-json\/wp\/v2\/media?parent=2694"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neuropediatoolkit.org\/en\/wp-json\/wp\/v2\/categories?post=2694"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neuropediatoolkit.org\/en\/wp-json\/wp\/v2\/tags?post=2694"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}